Correction to: HDACi mediate UNG2 depletion, dysregulated genomic uracil and altered expression of oncoproteins and tumor suppressors in B- and T-cell lines

Tobias S Iveland; Lars Hagen; Animesh Sharma; Mirta M L Sousa; Antonio Sarno; Kristian Lied Wollen; Nina Beate Liabakk; Geir Slupphaug

doi:10.1186/s12967-021-02896-1

Correction to: HDACi mediate UNG2 depletion, dysregulated genomic uracil and altered expression of oncoproteins and tumor suppressors in B- and T-cell lines

J Transl Med. 2021 Jun 4;19(1):243. doi: 10.1186/s12967-021-02896-1.

Authors

Tobias S Iveland^{1

2}, Lars Hagen^{1

3

4}, Animesh Sharma^{1

3

4}, Mirta M L Sousa^{1

3}, Antonio Sarno^{1

3}, Kristian Lied Wollen¹, Nina Beate Liabakk^{1

3}, Geir Slupphaug^{5

6

7}

Affiliations

¹ Department of Clinical and Molecular Medicine, Faculty of Medicine and Health, Norwegian University of Science and Technology, 7491, Trondheim, Norway.
² Cancer Clinic, St. Olav's Hospital, Trondheim, Norway.
³ Clinic of Laboratory Medicine, St. Olav's Hospital, Trondheim, Norway.
⁴ Proteomics and Modomics Experimental Core, PROMEC, at NTNU and the Central Norway Regional Health Authority, Stjørdal, Norway.
⁵ Department of Clinical and Molecular Medicine, Faculty of Medicine and Health, Norwegian University of Science and Technology, 7491, Trondheim, Norway. geir.slupphaug@ntnu.no.
⁶ Clinic of Laboratory Medicine, St. Olav's Hospital, Trondheim, Norway. geir.slupphaug@ntnu.no.
⁷ Proteomics and Modomics Experimental Core, PROMEC, at NTNU and the Central Norway Regional Health Authority, Stjørdal, Norway. geir.slupphaug@ntnu.no.

No abstract available

Publication types

Published Erratum